Cogent Biosciences, Inc.·4

Feb 15, 3:50 PM ET

Sachs Jessica 4

4 · Cogent Biosciences, Inc. · Filed Feb 15, 2023

Insider Transaction Report

Form 4
Period: 2023-02-13
Sachs Jessica
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-13+160,000160,000 total
    Exercise: $13.63Exp: 2033-02-13Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]This stock option shall vest in equal monthly installments over a four year period.

Documents

2 files